Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01DA064144 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | This group will receive payment for providing urine samples throughout the trial. | |
| Contingency Management Group | Experimental | This group will receive payment for providing methamphetamine negative urine samples throughout the trial. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Contingency Management | Behavioral | Subjects will receive payments for providing methamphetamine negative urine samples. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | At baseline. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 1 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 2 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 3 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 4 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 5 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 6 of participation. |
| Mean Arterial Pressure |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep | Sleep will be measured with the Pittsburgh Sleep Quality Index, with a range from 0-21 where lower scores are better. | At baseline. |
| Sleep | Sleep will be measured with the Pittsburgh Sleep Quality Index, with a range from 0-21 where lower scores are better. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| William W Stoops, PhD | Contact | 8592575388 | william.stoops@uky.edu |
| Name | Affiliation | Role |
|---|---|---|
| William W Stoops, PhD | University of Kentucky | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Psychopharmacology of Addiction Laboratory | Recruiting | Lexington | Kentucky | 40507 | United States |
De-identified participant level data will be findable and identifiable using the unique number assigned to this grant application by NIDA. Where the data are available and how to access the data will be identified in any publications and presentations about these data. The repository and funding source will also be acknowledged in any publications and presentations. The Open Science Framework, which is a generalist repository, will be the data repository. This repository has policies and procedures in place that will provide data access to qualified researchers.
No later than one year after the completion of the funded project period. Data will be available indefinitely after that.
Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and could be used for secondary study purposes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg
| Week 7 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure was recorded during subject visits and is recorded in mm Hg | Week 8 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 8 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 9 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 10 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 11 of participation. |
| Mean Arterial Pressure | Mean Arterial Pressure is recorded during subject visits and is recorded in mm Hg | Week 12 of participation. |
| Endothelin-1 | Endothelin-1 levels will be measured. They will be recorded in pg/ml. | At baseline. |
| Endothelin-1 | Endothelin-1 levels will be measured. They will be recorded in pg/ml. | Week 6 of participation. |
| Endothelin-1 | Endothelin-1 levels will be measured. They will be recorded in pg/ml. | Week 12 of participation. |
| Week 4 of participation. |
| Sleep | Sleep will be measured with the Pittsburgh Sleep Quality Index, with a range from 0-21 where lower scores are better. | Week 8 of participation. |
| Sleep | Sleep will be measured with the Pittsburgh Sleep Quality Index, with a range from 0-21 where lower scores are better. | Week 12 of participation. |